Navigation Links
Mainz University collaborates with 3 Chinese universities in research and teaching
Date:11/11/2013

The Institute of Sports Science at Johannes Gutenberg University Mainz (JGU) will be collaborating with three Chinese universities in the fields of research and teaching. The agreements cover such as aspects as research projects in high-performance sports to health care courses for students. One joint project in the field of high-performance sports is planned with the Chinese Institute of High-Altitude Medical Science Research in Xining, Tibet. Teaching and learning methods are to be analyzed in cooperation with the University of Wuhan, known for the numerous Olympic medal winners in martial arts, gymnastics, and water sports it has produced. A third agreement has been signed with the Shanghai University of Traditional Chinese Medicine (TCM). This will enable students studying Sports Science in Mainz to receive additional training in TCM in the form of block courses to be held in Germany and Shanghai.

"By means of these joint projects based on agreements with the individual universities, we are intentionally gaining access to new teaching and learning methods and the eastern philosophies on which they are based," said Professor Wolfgang Schllhorn of the Exercise and Movement Science section at JGU's Institute of Sports Science.

The first project in cooperation with the Chinese Institute of High-Altitude Medical Science Research will examine the question of what impact exercising at altitudes of 2,500 to 4,500 meters can have and how altitude training can be specifically used to improve performance. The project will compare athletes born and bred at such high altitudes with those born in lowland areas and examine the relevant genetic aspects. Working in collaboration with sports medicine specialists, various training scenarios will be tested within this altitude range. The specialists in exercise and movement from Mainz also intend to try out innovative procedures such as differential learning and new analytical methods.

The second project will involve collaboration with the University of Wuhan and will look at how training can be made more effective and to what extent training methods influence performance. "Wuhan is one of China's true gold medal factories, particularly when it comes to wrestling and the martial arts, gymnastics and rowing," explained Schllhorn. "What interests us is the extent to which athletes in the classic sports disciplines can profit from additional Qigong exercises and the use of differential learning techniques."

One of the main focuses of the third program will be on the use of Traditional Chinese Medicine in health care. Students who are not studying medicine will have the opportunity to take part in an intensive three-month course in TCM. The theoretical part of the course will involve Chinese teachers coming to Mainz for about one month; the course participants will then go to Shanghai for practical and theoretical training in TCM. The first course is scheduled to start in March 2014.


'/>"/>

Contact: Dr. Wolfgang Schöllhorn
move.brain@uni-mainz.de
49-613-139-23503
Johannes Gutenberg Universitaet Mainz
Source:Eurekalert

Related biology news :

1. Scientists at Mainz University decode mechanisms of cell orientation in the brain
2. Scientists from Mainz and Antananarivo describe Lavasoa Dwarf Lemur as new primate species
3. Mainz scientists confirm original tetrahedral model of the molecular structure of water
4. Mainz University Medical Center agrees partnership with Yale University
5. Scientists from Bangalore and Mainz develop new methods for cooling of ions
6. Mainz University coordinates new EU project on the origins of human settlement
7. Mainz University Medical Center attracts funding of Alexander von Humboldt Professorship
8. Research by Saint Louis University scientists offers way to disrupt fibrosis
9. Durbin, University of Illinois announce $25 million federal grant
10. University of Louisville researchers sign global licensing agreement
11. Queens University in €6m bid to find new Cystic Fibrosis treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... March 2, 2017 Summary This report ... and its partnering interests and activities since 2010. ... Read the full ... Alliance since 2010 report provides an in-depth insight into the ... companies. On demand company reports are prepared upon ...
(Date:3/2/2017)... 2017 Australian stem cell and regenerative medicine ... signed an agreement with the Monash Lung Biology Network, ... Institute and Department of Pharmacology at Monash University, ... study to support the use of Cymerus™ mesenchymal stem ... Asthma is a chronic, long term lung condition ...
(Date:2/28/2017)... , February 28, 2017 News solutions for ... ... from 14 to 16 March, Materna will present ... show how seamless travel is a real benefit for passengers. ... biometrics to their passenger touch point solutions to take passengers through ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... According to a report by Transparency Market ... due to the presence of a large pool of participants; however, ... , and Sigma-Aldrich, compete with each other in this market. With ... than 76% of this market in 2016.  ... As of now, a large number of ...
(Date:3/23/2017)... 2017 In today,s pre-market research, ... the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate ... SYN), and Regulus Therapeutics Inc. (NASDAQ: RGLS ... Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn ... at: ...
(Date:3/22/2017)... 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today ... (RGC), U.K. Biobank and GSK to generate genetic sequence data ... The initiative will enable researchers to gain valuable insights to ... wide range of serious and life threatening diseases. ... Genetic evidence ...
(Date:3/22/2017)... , March 22, 2017  Ascendis Pharma A/S ... innovative TransCon technology to address significant unmet medical ... for the full year ended December 31, 2016. ... for our company as we broadened our pipeline ... integrated rare disease company with an initial focus ...
Breaking Biology Technology: